Autoantibodies to the adenosine triphosphate synthase play a pathogenetic role in Alzheimer's disease

Neurobiology of Aging

Volumn 33, Issue 4, 2012, Pages 753-766

  Vacirca, D ^a   Delunardo, F ^a   Matarrese, P ^a   Colasanti, T ^a,b   Margutti, P ^a   Siracusano, A ^a   Pontecorvo, S ^c   Capozzi, A ^c   Sorice, M ^c   Francia, A ^c   Malorni, W ^a,b   Ortona, E ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b Istituto San Raffaele   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Adenosine triphosphate synthase subunit; Alzheimer's disease; Apoptosis; Autoantibodies; Diagnosis; Mitochondria; Pathogenesis

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE SYNTHASE BETA SUBUNIT; AUTOANTIBODY; SYNTHETASE; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BRAIN TISSUE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LOCALIZATION; FEMALE; HUMAN; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOSINE TRIPHOSPHATE; ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANIMALS; ANNEXIN A5; APOPTOSIS; AUTOANTIBODIES; BRAIN; CELL LINE, TUMOR; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MIDDLE AGED; MITOCHONDRIAL PROTON-TRANSLOCATING ATPASES; MULTIPLE SCLEROSIS; NEUROBLASTOMA; SEQUENCE ALIGNMENT; TIME FACTORS; YOUNG ADULT;

EID: 84856953499     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2010.05.013     Document Type: Article

References (46)

1. Boison D. Adenosine as a neuromodulator in neurological diseases. Curr. Opin. Pharmacol 2008, 8:2-7.
2. Bowman G.L., Kaye J.A., Moore M., Waichunas D., Carlson N.E., Quinn J.F. Blood-brain barrier impairment in Alzheimer disease: stability and functional significance. Neurology 2007, 68:1809-1814.
3. Brewer G.J. Effects of acidosis on the distribution of processing of the beta-amyloid precursor protein in cultured hippocampal neurons. Mol. Chem. Neuropathol 1997, 31:171-186.
4. Burrell H.E., Wlodarski B., Foster B.J., Buckley K.A., Sharpe G.R., Quayle J.M., Simpson A.W., Gallagher J.A. Human keratinocytes release ATP and utilize three mechanisms for nucleotide interconversion at the cell surface. J. Biol. Chem 2005, 280:29667-29676.
5. Burwick N.R., Wahl M.L., Fang J., Zhong Z., Moser T.L., Li B., Capaldi R.A., Kenan D.J., Pizzo S.V. An Inhibitor of the F1 subunit of ATP synthase (IF1) modulates the activity of angiostatin on the endothelial cell surface. J. Biol. Chem 2005, 280:1740-1745.
6. Cacabelos R., Fernandez-Novoa L., Lombardi V., Kubota Y., Takeda M. Molecular genetics of Alzheimer's disease and aging. Methods Find. Exp. Clin. Pharmacol 2005, 27:1-573.
7. Champagne E., Martinez L.O., Collet X., Barbaras R. Ecto-F1Fo ATP synthase/F1 ATPase: metabolic and immunological functions. Curr. Opin. Lipidol 2006, 17:279-284.
8. Chi S.L., Pizzo S.V. Angiostatin is directly cytotoxic to tumor cells at low extracellular pH: a mechanism dependent on cell surface-associated ATP synthase. Cancer Res 2006, 66:875-882.
9. Chi S.L., Pizzo S.V. Cell surface F1Fo ATP synthase: a new paradigm?. Ann. Med 2006, 38:429-438.
10. Chi S.L., Wahl M.L., Mowery Y.M., Shan S., Mukhopadhyay S., Hilderbrand S.C., Kenan D.J., Lipes B.D., Johnson C.E., Marusich M.F., Capaldi R.A., Dewhirst M.W., Pizzo S.V. Angiostatin-like activity of a monoclonal antibody to the catalytic subunit of F1F0 ATP synthase. Cancer Res 2007, 67:4716-4724.
11. Cossarizza A., Franceschi C., Monti D., Salvioli S., Bellesia E., Rivabene R., Biondo L., Rainaldi G., Tinari A., Malorni W. Protective effect of N-acetylcysteine in tumor necrosis factor-alpha-induced apoptosis in U937 cells: the role of mitochondria. Exp. Cell Res 1995, 220:232-240.
12. D'Andrea M.R. Evidence linking neuronal cell death to autoimmunity in Alzheimer's disease. Brain Res 2003, 982:19-30.
13. D'Andrea M.R. Add Alzheimer's disease to the list of autoimmune diseases. Med. Hypotheses 2005, 64:458-463.
14. Delunardo F., Conti F., Margutti P., Alessandri C., Priori R., Siracusano A., Riganò R., Profumo E., Valesini G., Sorice M., Ortona E. Identification and characterization of the carboxy-terminal region of Sip-one, a novel autoantigen in Behcet's disease. Arthritis Res. Ther 2006, 8:R71.
15. Delunardo F., Margutti P., Pontecorvo S., Colasanti T., Conti F., Riganò R., Profumo E., Siracusano A., Capozzi A., Prencipe M., Sorice M., Francia A., Ortona E. Screening of a microvascular endothelial cDNA library identifies rabaptin five as a novel autoantigen in Alzheimer's disease. J. Neuroimmunol 2007, 192:105-112.
16. Donahue J.E., Johanson C.E. Apolipoprotein E, amyloid-beta, and blood-brain barrier permeability in Alzheimer disease. J. Neuropathol. Exp. Neurol 2008, 67:261-270.
17. Garboczi D.N., Shenbagamurthi P., Kirk W., Hullihen J., Pedersen P.L. Mitochondrial ATP synthase. Interaction of a synthetic fifty-amino acid, beta-subunit peptide with ATP. J. Biol. Chem 1988, 263:812-816.
18. Hunya A., Földi I., Szegedi V., Soós K., Zarándi M., Szabò A., Zàdori D., Penke B., Datki Z.L. Differences between normal and alpha-synuclein overexpressing SH-SY5Y neuroblastoma cells after Abeta (1-42) and NAC treatment. Brain Res. Bull 2008, 75:648-654.
19. Knopman D.S., deKosky S.T., Cummings J.L., Chui H., Corey-Bloom J., Relkin N., Small G.W., Miller B., Stevens J.C. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001, 56:1143-1153.
20. Lagadic-Gossmann D., Huc L., Lecureu V. Alterations of intracellular pH homeostasis in apoptosis: origins and roles. Cell Death Differ 2004, 11:953-961.
21. Le Lay S., Krief S., Farnier C., Lefrère I., Le Liepvre X., Bazin R., Ferré P., Dugail I. Cholesterol, a cell size-dependent signal that regulates glucose metabolism and gene expression in adipocytes. J. Biol. Chem 2001, 276:16904-16910.
22. Ly J.D., Grubb D.R., Lawen A. The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update. Apoptosis 2003, 8:115-128.
23. Margutti P., Delunardo F., Sorice M., Valesini G., Alessandri C., Capoano R., Profumo E., Siracusano A., Salvati B., Riganò R., Ortona E. Screening of a HUAEC cDNA library identifies actin as a candidate autoantigen associated with carotid atherosclerosis. Clin. Exp. Immunol 2004, 137:209-215.
24. Margutti P., Matarrese P., Conti F., Colasanti T., Delunardo F., Capozzi A., Garofalo T., Profumo E., Riganò R., Siracusano A., Alessandri C., Salvati B., Valesini G., Malorni W., Sorice M., Ortona E. Autoantibodies to the C-terminal subunit of RLIP76 induce oxidative stress and endothelial cell apoptosis in immune-mediated vascular diseases and atherosclerosis. Blood 2008, 111:4559-4570.
25. Margutti P., Sorice M., Conti F., Delunardo F., Racaniello M., Alessandri C., Siracusano A., Riganò R., Profumo E., Valesini G., Ortona E. Screening of an endothelial cDNA library identifies the C-terminal region of Nedd5 as a novel autoantigen in systemic lupus erythematosus with psychiatric manifestations. Arthritis Res. Ther 2005, 7:896-903.
26. Matarrese P., Cauda R., Malorni W. Activation-associated mitochondrial hyperpolarization hijacks T cells toward an apoptosis-sensitized phenotype. Cell Death Differ 2003, 10:609-611.
27. Matarrese P., Di Biase L., Santodonato L., Straface E., Mecchia M., Ascione B., Parmiani G., Belardelli F., Ferrantini M., Malorni W. Type I interferon gene transfer sensitizes melanoma cells to apoptosis via a target activity on mitochondrial function. Am. J. Pathol 2002, 160:507-520.
28. McDaniel L.D., Lukovits T., McDaniel K.D. Alzheimer's disease: the problem of incorrect clinical diagnosis. J. Geriatr. Psychiatry Neurol 1993, 6:230-234.
29. Mormone E., Matarrese P., Tinari A., Cannella M., Maglione V., Farrace M.G., Piacentini M., Frati L., Malorni W., Squitieri F. Genotype-dependent priming to self- and xeno-cannibalism in heterozygous and homozygous lymphoblasts from patients with Huntington disease. J. Neurochem 2006, 98:1090-1099.
30. Moser T.L., Kenan D.J., Ashley T.A., Roy J.A., Goodman M.D., Misra U.K., Cheek D.J., Pizzo S.V. Endothelial cell surface F1-F0 ATP synthase is active in ATP synthesis and is inhibited by angiostatin. Proc. Natl. Acad. Sci. USA 2001, 98:6656-6661.
31. Musante L., Candiano G., Bruschi M., Santucci L., Carnemolla B., Orecchia P., Giampuzzi M., Zennaro C., Sanna-Cherchi S., Carraro M., Oleggini R., Camussi G., Perfumo F., Ghiggeri G.M. Circulating anti-actin and anti-ATP synthase antibodies identify a sub-set of patients with idiopathic nephrotic syndrome. Clin. Exp. Immunol 2005, 141:491-499.
32. Nussbaum R.L., Ellis C.E. Alzheimer's disease and Parkinson's disease. N Engl J. Med 2003, 348:1356-1364.
33. Pirchl M., Marksteiner J., Humpel C. Effects of acidosis on brain capillary endothelial cells and cholinergic neurons: relevance to vascular dementia and Alzheimer's disease. Neurol. Res 2006, 28:657-664.
34. Poppe M., Reimertz C., Düssmann H., Krohn A.J., Luetjens C.M., Böckelmann D., Nieminen A.L., Kögel D., Prehn J.H. Dissipation of potassium and proton gradients inhibits mitochondrial hyperpolarization and cytochrome c release during neural apoptosis. J. Neurosci 2001, 21:4551-4563.
35. Schmidt C., Lepsverdize E., Chi S.L., Das A.M., Pizzo S.V., Dityatev A., Schachner M. Amyloid precursor protein and amyloid beta-peptide bind to ATP synthase and regulate its activity at the surface of neural cells. Mol. Psychiatry 2008, 13:953-969.
36. Shoenfeld Y., Gershwin E.M., Meroni P.L. Autoantibodies 2007, Elsevier. 2nd Ed.
37. Stock D., Andrew G., Leslie W., Walker J.E. Molecular architecture of the rotary motor in ATP synthase. Science 1999, 286:1700-1705.
38. Stulík J., Hernychová L., Porkertová S., Pozler O., Tucková L., Sànchez D., Bures J. Identification of new celiac disease autoantigens using proteomic analysis. Proteomics 2003, 3:951-956.
39. Sung Y.H., Shin M.S., Cho S., Baik H.H., Jin B.K., Chang H.K., Lee E.K., Kim C.J. Depression-like state in maternal rats induced by repeated separation of pups is accompanied by a decrease of cell proliferation and an increase of apoptosis in the hippocampus. Neurosci. Lett 2010, 470:86-90.
40. Vantourout P., Martinez L.O., Fabre A., Collet X., Champagne E. Ecto-F1-ATPase and MHC-class I close association on cell membranes. Mol. Immunol 2008, 45:485-492.
41. von Bernhardi R., Eugenín J. Microglial reactivity to β-amyloid is modulated by astrocytes and proinflammatory factors. Brain Res 2004, 1025:186-193.
42. Wang H., Xu Y., Yan J., Zhao X., Sun X., Zhang Y., Guo J., Zhu C. Acteoside protects human neuroblastoma SH-SY5Y cells against beta-amyloid-induced cell injury. Brain Res 2009, 1283:139-147.
43. Weiner H.L., Selkoe D.J. Inflammation and therapeutic vaccination in CNS diseases. Nature 2002, 420:879-884.
44. Weisová P., Concannon C.G., Devocelle M., Prehn J.H., Ward M.W. Regulation of glucose transporter three surface expression by the AMP-activated protein kinase mediates tolerance to glutamate excitation in neurons. J. Neurosci 2009, 29:2997-3008.
45. Yamamoto K., Shimizu N., Obi S., Kumagaya S., Taketani Y., Kamiya A., Ando J. Involvement of cell surface ATP synthase in flow-induced ATP release by vascular endothelial cells. Am. J. Physiol. Heart Circ. Physiol 2007, 293:1646-1653.
46. Zipser B.D., Johanson C.E., Gonzalez L., Berzin T.M., Tavares R., Hulette C.M., Vitek M.P., Hovanesian V., Stopa E.G. Microvascular injury and blood-brain barrier leakage in Alzheimer's disease. Neurobiol. Aging 2007, 28:977-986.